Virbac has launched Marfloquin, a marbofloxacin-based antibiotic indicated for the treatment of multiple infectious diseases in cats and dogs. 

Marfloquin is presented as a palatable, divisible tablet for once daily administration and is available…

Virbac has launched Pronefra, a palatable phosphate-binder to aid with the management of chronic kidney disease (CKD) in cats and dogs.

The company says that managing blood phosphate levels is regarded as one of the most important aspects of managing…

Virbac has launched Curacef Duo, a unique combination of antibiotic and NSAID offering an alternative approach to the treatment of bovine respiratory disease (BRD) caused by Mannhaemia haemolytica and Pasteurella multocida. 

Containing ceftiofur (50mg…

Virbac's calf scour vaccine, Bovigen Scour, has been granted VMD approval for a single-shot vaccination protocol in pregnant cows and heifers, and had its shelf life extended to 3 years.

Virbac says that this means that irrespective of previous vaccination…

Virbac has launched Equipred (prednisolone), the first licensed steroid tablet for horses.

Licensed for the treatment of severe equine asthma, each Equipred tablet contains 50mg of prednisolone, a larger concentration tablet designed to make dosing easier…

Virbac has launched two wet diets for cats, formulated to help prevent and manage Feline Lower Urinary Tract Disease.

The new Veterinary HPM Adult Neutered Wet with Salmon (a lifestage diet) and Urology Cat Wet (a clinical diet) have a high-protein low…

Virbac has been appointed as the exclusive distributor of Syvazul BTV3, a bluetongue vaccine made by Spanish pharmaceutical company, Syva, the first doses of which have already arrived in the UK.

The announcement came hot on the heels of announcements…

Virbac has launched Trilotab, the first chewable, flavoured and divisible trilostane tablet to treat Cushing’s syndrome in dogs.

Trilotab is licensed for the treatment of pituitary-dependent hypercortisolism (PDH) caused by an adrenocorticotrophic…

Virbac has launched Vikaly, a world-first medicated renal diet which contains the ACE inhibitor benazepril.

Vikaly is indicated for the nutritional and medical management of chronic kidney disease in adult and senior cats with proteinuria, from IRIS stage…

Virbac has acquired Thyronorm (thiamazole), the leading treatment for feline hyperthyroidism, from Norbrook. 

Marketed since 2016, Thyronorm is an award-winning liquid formulation that simplifies administration compared to tablets and enables precise dosing…